Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02323165 · ClinicalTrials.gov registry record
A New Method for Detection of Bacteria in the Bloodstream
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 14
- Enrollment target
NCT02323165: Completed study, sponsored by University of Florida.
NCT02323165 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02323165 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The primary aim is to determine if this new technique will detect and identify bacteria in the blood sooner than standard blood cultures or identify patients who may be septic without growing bacteria in their cultures. These will be correlated with the data collected from medical records on presumed sepsis. These results will be linked to data concerning infection that will be available as part of routine care including blood counts and other laboratory values that would be part of the routine medical care such as a white blood cell count. The earlier the bacteria are identified and the appropriate antimicrobials are administered the better the patient outcome.
Primary Outcome
Extracted nucleic acid will be tested by PCR with "universal" bacterial 16 S primers that we have identified as not amplifying a product from known 16 S sequences that routinely contaminate reagents.PCR will be performed by both TaqMan assays we have developed that can provide quantitative copy numbers, as well as traditional PCR that can produce products that can be sequenced to confirm bacterial species identification.
Interventions
- OTHER Molecular Detection of Bacteria in the Bloodstream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-01 |
| Est. Completion | 2022-03-04 |
What the finished NCT02323165 record still lists
NCT02323165 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Molecular Detection of Bacteria in the Bloodstream is the first listed.
NCT02323165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02323165 about?
NCT02323165 is a clinical study titled "A New Method for Detection of Bacteria in the Bloodstream". The primary aim is to determine if this new technique will detect and identify bacteria in the blood sooner than standard blood cultures or identify patients who may be septic without growing bacteria in their cultures. These will be correlated with the data collected from medical records on presume...
What is the current status of trial NCT02323165?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2015-01. Estimated completion is 2022-03-04.
What interventions are being tested in trial NCT02323165?
The interventions under investigation include: Molecular Detection of Bacteria in the Bloodstream (OTHER).
Who is sponsoring clinical trial NCT02323165?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia